Clinical Trial Update: Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib [Phase 1, Phase 2]

View source ↗

Summary

Clinical study evaluating anlotinib for recurrent glioblastoma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Recurrent Glioblastoma | Phase 1, Phase 2 | Status: UNKNOWN